English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduNanodecoys made from human lung spheroid cells (LSCs) can bind to and neutralize SARS-CoV-2, promoting viral clearance and reducing lung injury in a macaque model of COVID-19.
Tag: SARS COV-2
Study Identifies How COVID-19 Linked to Alzheimer’s Disease-like Cognitive Impairment
A new Cleveland Clinic-led study has identified mechanisms by which COVID-19 can lead to Alzheimer’s disease-like dementia. The findings, published in Alzheimer’s Research & Therapy, indicate an overlap between COVID-19 and brain changes common in Alzheimer’s, and may help inform risk management and therapeutic strategies for COVID-19-associated cognitive impairment.
Researchers Discover Drug that Blocks Multiple SARS-CoV-2 Variants in Mice
A small molecule STING agonist was highly protective against the virus that causes COVID-19 and likely other coronaviruses
Fadiga, percepção de comprometimento cognitivo e transtornos do humor estão associados à síndrome pós-COVID-19, revela estudo da Mayo Clinic
Pacientes diagnosticados com síndrome pós COVID-19, também conhecida como “PCS”, “síndrome de COVID de longa duração” e “sequelas pós-agudas de SARS COV-2”, apresentam sintomas como transtornos de humor, fadiga e comprometimento cognitivo que podem afetar negativamente o retorno ao trabalho e a retomada de atividades normais.
Gut Protein + ACE2 Form Functional Unit, Explains COVID-19 Gastrointestinal Symptoms
Research published ahead of print in the journal Function suggests the relationship between angiotensin converting enzyme 2 (ACE2) and the sodium-dependent neutral amino acid transporter B(0)AT1, a protein found in the intestines, form a physiological “functional unit.” ACE2, an enzyme…